Pershing Square proposes a slate of independent directors for Allergan


Bill Ackman's Pershing Square Capital Management just happens to have a list of six BOD candidates that it believes would be a superb fit at Allergan (AGN -1.5%) just in case shareholders vote to replace six incumbent board members at the special meeting it is attempting to schedule.

Four of the six are institutional investors. I wonder how they would vote on Valeant's (VRX -2%) offer?

From other sites
Comments (4)
  • tom2be
    , contributor
    Comments (30) | Send Message
     
    "How to ruin a company" by Bill Ackman
    7 Jul 2014, 01:21 PM Reply Like
  • youhavetobekidding
    , contributor
    Comments (6) | Send Message
     
    how to also ruin lives, destroy a local community, leave a large number of people unemployed which will grow to almost all of the former Allergan staff over a years time. all in the name of making a relatively small group of people a ton of money.

     

    It will also further stifle innovation and research in the pharmaceutical industry. and move a significant amount of tax earnings outside the US.

     

    This last week Pearson and his team finished all the B+L layoff announcements in the Irvine area, everyone will be gone in the next few months with the cancellation of all the clinical studies that were underway at that facility.

     

    if these deal goes through and with Ackman's and Pearson's ruthless uncaring attitude and the amount of lies being told about the Valeant business model it likely well. everyone should start to look to go outside the US for eyecare, we will descend into a third world eyecare country just like most of our other medical/pharmaceutical industry.
    7 Jul 2014, 02:00 PM Reply Like
  • caffeinefiend
    , contributor
    Comment (1) | Send Message
     
    I understand your comment. I am a former B+L employee (left on my own, not due to Valeant's hatchet) and witnessed what Valeant did to B+L in the Northeast. Valeant has no interest in inovation or development. Valeant is driven soley by greed and ego. If you are a short term investor, you can make money at this time but, the Valeant wheels will come off as Pearson's strategy is unsustainable for the long term.
    7 Jul 2014, 05:46 PM Reply Like
  • pandgcardi@yahoo.com
    , contributor
    Comments (2) | Send Message
     
    Valeant is a swarm of locusts, ecstatic about the chance to destroy capitalism's and mankind's greatest treasure of this era: private pharma R&D. It's too bad when the pigs find a niche like this in the machinery of commerce where they can to so much harm to so many millions, even billions, of people and undermine the very purpose and reputation of capitalism itself. Pure greed is not always a great thing. These locusts are just unfeeling insects that smell food. These are the lowest of the low, on a scale with the ones who happily supplied Hitler with the furnaces and gas showers for the death camps.
    9 Jul 2014, 12:02 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs